GSK
840 hedge funds and large institutions have $14.2B invested in GSK in 2025 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 324 increasing their positions, 272 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
840
Holders Change
+5
Holders Change %
+0.6%
% of All Funds
11.41%
Holding in Top 10
14
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+16.67%
% of All Funds
0.19%
New
90
Increased
324
Reduced
272
Closed
65
Calls
$243M
Puts
$146M
Net Calls
+$96.9M
Net Calls Change
-$258M
Top Buyers
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$434M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$396M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$283M |
| 4 |
Holocene Advisors
New York
|
+$186M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$103M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MFG
901
Mendota Financial Group
Madison,
Wisconsin
| – | -$880 | -26 | Closed |
|
902
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$812 | -24 | Closed |
|
|
PFA
903
Pillar Financial Advisors
Louisville,
Kentucky
| – | -$102 | -3 | Closed |
|
|
CJ
904
Caitlin John
Brighton,
Michigan
| – | -$68 | -2 | Closed |
|
|
LOIP
905
Live Oak Investment Partners
Austin,
Texas
| – | -$2.91K | – | – |
|